Search Results - "Blatt, Katharina"
-
1
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Published in Journal of allergy and clinical immunology (01-05-2015)“…Background Grass pollen is one of the most important sources of respiratory allergies worldwide. Objective This study describes the development of a grass…”
Get full text
Journal Article -
2
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Published in Blood (19-06-2014)“…Chronic myeloid leukemia (CML) is a stem cell (SC) neoplasm characterized by the BCR/ABL1 oncogene. Although mechanisms of BCR/ABL1-induced transformation are…”
Get full text
Journal Article -
3
Identification of a leukemia-initiating stem cell in human mast cell leukemia
Published in Leukemia (01-11-2019)“…Mast cell leukemia (MCL) is a highly fatal malignancy characterized by devastating expansion of immature mast cells in various organs. Although considered a…”
Get full text
Journal Article -
4
Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications
Published in Experimental hematology (01-07-2017)“…Chronic myeloid leukemia (CML) is a stem cell–derived leukemia in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein…”
Get full text
Journal Article -
5
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Published in Clinical cancer research (15-04-2016)“…In chronic myelogenous leukemia (CML), leukemic stem cells (LSC) represent a critical target of therapy. However, little is known about markers and targets…”
Get full text
Journal Article -
6
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
Published in EBioMedicine (01-09-2016)“…We have developed a recombinant B cell epitope-based vaccine (BM32) for allergen-specific immunotherapy (AIT) of grass pollen allergy. The vaccine contains…”
Get full text
Journal Article -
7
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection
Published in Blood (03-07-2014)“…In systemic mastocytosis (SM), clinical problems arise from factor-independent proliferation of mast cells (MCs) and the increased release of mediators by MCs,…”
Get full text
Journal Article -
8
Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy
Published in Journal of allergy and clinical immunology (01-08-2012)“…Background More than 50% of allergic patients have house dust mite (HDM) allergy. Group 1 and 2 allergens are the major HDM allergens. Objective We sought to…”
Get full text
Journal Article -
9
Phenotyping and Target Expression Profiling of CD34+/CD38− and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
Published in Neoplasia (New York, N.Y.) (01-06-2018)“…Leukemic stem cells (LSCs) are an emerging target of curative anti-leukemia therapy. In acute lymphoblastic leukemia (ALL), LSCs frequently express CD34 and…”
Get full text
Journal Article -
10
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
Published in Haematologica (Roma) (01-09-2017)“…In chronic myeloid leukemia, resistance against BCR-ABL1 tyrosine kinase inhibitors can develop because of mutations, activation of additional pro-oncogenic…”
Get full text
Journal Article -
11
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
Published in Haematologica (Roma) (01-05-2018)“…Systemic mastocytosis is a complex disease defined by abnormal growth and accumulation of neoplastic mast cells in various organs. Most patients exhibit a…”
Get full text
Journal Article -
12
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
Published in Journal of allergy and clinical immunology (01-02-2016)“…Background Late allergic reactions are common in the course of allergen-specific immunotherapy and even occur with allergy vaccines with reduced IgE…”
Get full text
Journal Article -
13
Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
Published in PloS one (22-08-2016)“…The house dust mite (HDM) allergen Der p 18 belongs to the glycoside hydrolase family 18 chitinases. The relevance of Der p 18 for house dust mite allergic…”
Get full text
Journal Article -
14
Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5
Published in Journal of allergy and clinical immunology (01-03-2014)“…Background The major timothy grass pollen allergen Phl p 5 belongs to the most potent allergens involved in hay fever and asthma. Objective This study…”
Get full text
Journal Article -
15
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
Published in Haematologica (Roma) (01-09-2013)“…Patients with advanced systemic mastocytosis, including mast cell leukemia, have a poor prognosis. In these patients, neoplastic mast cells usually harbor the…”
Get full text
Journal Article -
16
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia
Published in Critical reviews in oncology/hematology (01-04-2014)“…Abstract Disordered stem cell epigenetics and apoptosis-regulating mechanisms contribute essentially to the pathogenesis of myelodysplastic syndromes (MDS) and…”
Get full text
Journal Article -
17
Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
Published in Journal of allergy and clinical immunology (01-08-2015)“…In a subsequent series of experiments, we demonstrated that P2/ICAM1 can prevent the apical-to-basolateral penetration of Phl p 2 but not of the birch pollen…”
Get full text
Journal Article -
18
CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
Published in Haematologica (Roma) (01-02-2012)“…CD33 is a well-known stem cell target in acute myeloid leukemia. So far, however, little is known about expression of CD33 on leukemic stem cells in chronic…”
Get full text
Journal Article -
19
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils
Published in PloS one (27-01-2012)“…The phosphoinositide 3-kinase (PI3-kinase) and the mammalian target of rapamycin (mTOR) are two major signaling molecules involved in growth and activation of…”
Get full text
Journal Article -
20
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL
Published in PloS one (10-10-2013)“…Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is in part driven by the tyrosine kinase bcr-abl, but imatinib does not produce…”
Get full text
Journal Article